Numerai’s AngioDynamics ANGO Stock Holding History

Numerai’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,432	Closed	-$226K	–	158
2022 Q4	$226K	Buy	+16,432	New	+$229K	0.15%	103

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Numerai's ANGO Position: Q1 2023 in Review

Numerai sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 16,432 shares — an estimated $226K sold.

Numerai first reported a position in ANGO in Q4 2022 and held it in 1 quarter. The position peaked at $226K in Q4 2022. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.

Numerai reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
Numerai sold 16,432 AngioDynamics shares in Q1 2023, an estimated $226K.
Numerai first reported a position in AngioDynamics in Q4 2022 and held it in 1 quarter.
Numerai's AngioDynamics position peaked at $226K in Q4 2022.
153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.

Based on Numerai's 13F filing for Q1 2023, filed 12 May 2023.